DexCom (DXCM) Tops Q2 EPS by 8c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $68.86 -0.3%
EPS Growth %: +27.1%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +27.1%
Financial Fact:
Product revenue: 148.6M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.10), $0.08 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $242.5 million versus the consensus estimate of $205.68 million.
GUIDANCE:
DexCom sees FY2018 revenue of $925 million, versus the consensus of $862.2 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Dexcom Further Advances Vision of Glucose Biosensing for All
- DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
